Taylan, E. Et Al. 2017. Development of a treatment based on proteasomal inhibition and antioxidant usage in protein wasting observed in diabetes. 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back , (Jerusalem, Israel), 298-299.

Taylan, E., Doyuran, K., Micili, S. C., Kamaci, G., Guneli, E., & Resmi, H., (2017). Development of a treatment based on proteasomal inhibition and antioxidant usage in protein wasting observed in diabetes . 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back (pp.298-299). Jerusalem, Israel

Taylan, E. Et Al. "Development of a treatment based on proteasomal inhibition and antioxidant usage in protein wasting observed in diabetes," 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back, Jerusalem, Israel, 2017

Taylan, E. Et Al. "Development of a treatment based on proteasomal inhibition and antioxidant usage in protein wasting observed in diabetes." 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back , Jerusalem, Israel, pp.298-299, 2017

Taylan, E. Et Al. (2017) . "Development of a treatment based on proteasomal inhibition and antioxidant usage in protein wasting observed in diabetes." 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back , Jerusalem, Israel, pp.298-299.

@conferencepaper{conferencepaper, author={E. Taylan Et Al. }, title={Development of a treatment based on proteasomal inhibition and antioxidant usage in protein wasting observed in diabetes}, congress name={42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back}, city={Jerusalem}, country={Israel}, year={2017}, pages={298-299} }